Pharmaceutical company Biovitrum

Presenting Swedish Orphan Biovitrum

Biovitrum and Swedish Orphan have combined forming

Our new home page is under construction and for the time being we kindly refer to our current home pages: Link to Swedish Orphan International website.

Our products

Biovitrum is dedicated in helping people to a better life by developing new and innovative products to counter unmet medical needs

Presentation of Biovitrum's Interim Report January - June, 2010
The Interim Report for the second quarter 2010 will be published around 8.30 a.m. (CET) July 20. The Interim Report for the second quarter 2010 will be presented by Swedish Orphan Biovitrum´

June 24, 2010 - New short name on NASDAQ OMX Stockholm
Biovitrum AB (publ) will be listed under its new company name, Swedish Orphan Biovitrum AB (publ) with effect from June 24, 2010. New short name: SOBI Unchanged ISIN code: SE0000872095 Unc

Boy is playing Biovitrum and Biogen Idec Decide to Advance Hemophilia B Therapy into Registrational Trial

We develop rFIXFc for the treatment of hemophilia B, the goal being that patients will need less frequent prophylactic injections than with currently existing therapies. Read more ..